| Consumers Spurred J&J Recall Consumer complaints spurred an investigation that led to a recall of Johnson & Johnson children's medications because of manufacturing problems. online.wsj.com |
Obama Warns Insurers on Rates Obama told health-insurance executives they should keep a lid on big rate increases, but the executives said some rises were unavoidable because the new health law requires them to offer better benefits. online.wsj.com |
Scrutiny Turns to Retirement Centers A fast-growing sector of senior housing is coming under increased scrutiny in Washington—continuing-care retirement communities. online.wsj.com |
Idenix Hopes to Resume Course With Hepatitis C Drugs by Year's End The Burrill Report submits: By Michael FitzhughIdenix Pharmaceuticals (IDIX) halted a mid-stage study of two hepatitis C drugs after the U.S. Food and Drug Administration ordered it to suspend the trial over safety concerns. The news led investors to sink the company's shares on worries about the program's future. Complete Story » seekingalpha.com |
Enzo Biochem Initiates Clinical Trial for Treatment of Uveitis at NIH [Business Wire] - Enzo Biochem, Inc. , announced today that, following filing of a investigational new drug application with the FDA, its Enzo Therapeutics division is commencing a clinical trial of Optiquel™ , the Company’s proprietary oral therapeutic for chronic non-infectious uveitis. us.rd.yahoo.com |